Filana Therapeutics, Inc. (FLNA) Financials

FLNA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 108.4 million 40.2 million
Dec. 31, 2025 118.4 million 44.0 million
Sept. 30, 2025 129.7 million 48.2 million
June 30, 2025 135.4 million 47.4 million

FLNA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 ? ?
Dec. 31, 2025 -10.2 million 5.4 million
Sept. 30, 2025 -6.3 million 4.4 million
June 30, 2025 -4.9 million 4.6 million

FLNA Net Income

No data available :(

FLNA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 86.6 million - -
Dec. 31, 2025 95.5 million - -
Sept. 30, 2025 106.1 million - -
June 30, 2025 112.4 million - -

FLNA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 48.3 million
Dec. 31, 2025 48.3 million
Sept. 30, 2025 48.3 million
June 30, 2025 48.3 million

FLNA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 4.5 million 6.4 million -
Dec. 31, 2025 501000 3.9 million 9.3 million -
Sept. 30, 2025 80000 4.0 million 7.9 million -
June 30, 2025 - 5.1 million 40.3 million -

FLNA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 243000
Dec. 31, 2025 - 367000
Sept. 30, 2025 - -
June 30, 2025 - -

FLNA

Price: $1.22

52 week price:
1.16
4.98

Earnings Per Share: -1.61 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 69.6 million

Links: